WO2005049861A3 - Method for the analysis of gynaecological cell proliferative disorders - Google Patents
Method for the analysis of gynaecological cell proliferative disorders Download PDFInfo
- Publication number
- WO2005049861A3 WO2005049861A3 PCT/EP2004/012740 EP2004012740W WO2005049861A3 WO 2005049861 A3 WO2005049861 A3 WO 2005049861A3 EP 2004012740 W EP2004012740 W EP 2004012740W WO 2005049861 A3 WO2005049861 A3 WO 2005049861A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell proliferative
- analysis
- proliferative disorders
- gynaecological
- gynaecological cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04797788A EP1685260A2 (en) | 2003-11-10 | 2004-11-10 | Method for the analysis of gynaecological cell proliferative disorders |
JP2006538787A JP2007531512A (en) | 2003-11-10 | 2004-11-10 | Gynecological cell proliferation disorder analysis method |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03025739.8 | 2003-11-10 | ||
EP03025739 | 2003-11-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005049861A2 WO2005049861A2 (en) | 2005-06-02 |
WO2005049861A3 true WO2005049861A3 (en) | 2005-11-24 |
Family
ID=34610045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2004/012740 WO2005049861A2 (en) | 2003-11-10 | 2004-11-10 | Method for the analysis of gynaecological cell proliferative disorders |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1685260A2 (en) |
JP (1) | JP2007531512A (en) |
WO (1) | WO2005049861A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602004019451D1 (en) * | 2003-12-03 | 2009-03-26 | Whitehead Biomedical Inst | Use of soluble T-cadherin for the treatment of metabolic diseases |
CA2574165A1 (en) * | 2004-07-16 | 2006-01-26 | Oncomethylome Sciences S.A. | Esr1 and cervical cancer |
EP2626435B1 (en) * | 2008-03-21 | 2016-06-01 | MDxHealth S.A. | Detection and prognosis of cervical cancer |
EP2855705B1 (en) | 2012-05-25 | 2018-11-28 | The Hospital for Sick Children | Method of diagnosing cancer comprising detection of the methylation signature in the htert promoter |
US10597730B2 (en) | 2012-05-25 | 2020-03-24 | The Hospital For Sick Children | Method of diagnosing cancer |
EP2899275B1 (en) * | 2012-09-19 | 2018-06-27 | Sysmex Corporation | Method for obtaining information about endometrial cancer, and marker and kit for obtaining information about endometrial cancer |
CN106319053A (en) * | 2016-08-23 | 2017-01-11 | 山东大学齐鲁医院 | Method and kit for quantitative detection of effect of treating hepatic failure of glucocorticoid |
CN109825581A (en) * | 2019-02-28 | 2019-05-31 | 昆明理工大学 | A kind of primer, detection method, kit and application detecting RASSF1A gene methylation |
CN113278688A (en) * | 2021-07-07 | 2021-08-20 | 武汉凯德维斯生物技术有限公司 | Primer combination and kit for detecting HPV integration gene locus |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002024056A2 (en) * | 2000-09-20 | 2002-03-28 | Case Western Reserve University | METHODS AND COMPOSITIONS FOR DETECTING CANCERS ASSOCIATED WITH METHYLATION OF hMLH1PROMOTER DNA |
WO2004087957A2 (en) * | 2003-04-03 | 2004-10-14 | Oncomethylome Sciences S.A. | Hypermethylated genes and cervical cancer |
-
2004
- 2004-11-10 JP JP2006538787A patent/JP2007531512A/en not_active Withdrawn
- 2004-11-10 WO PCT/EP2004/012740 patent/WO2005049861A2/en active Application Filing
- 2004-11-10 EP EP04797788A patent/EP1685260A2/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002024056A2 (en) * | 2000-09-20 | 2002-03-28 | Case Western Reserve University | METHODS AND COMPOSITIONS FOR DETECTING CANCERS ASSOCIATED WITH METHYLATION OF hMLH1PROMOTER DNA |
WO2004087957A2 (en) * | 2003-04-03 | 2004-10-14 | Oncomethylome Sciences S.A. | Hypermethylated genes and cervical cancer |
Non-Patent Citations (8)
Title |
---|
BADAL VINAY ET AL: "CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: Genomic hypomethylation correlates with carcinogenic progression.", JOURNAL OF VIROLOGY, vol. 77, no. 11, June 2003 (2003-06-01), pages 6227 - 6234, XP002330532, ISSN: 0022-538X * |
DATABASE EMBL [online] 11 January 2000 (2000-01-11), "Homo sapiens BAC clone RP11-259G7 from 4, complete sequence.", XP002330537, retrieved from EBI accession no. EM_HUM:AC020703 Database accession no. AC020703 * |
FIEGL HEIDI ET AL: "Methylated DNA collected by tampons--a new tool to detect endometrial cancer.", CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION : A PUBLICATION OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, COSPONSORED BY THE AMERICAN SOCIETY OF PREVENTIVE ONCOLOGY. MAY 2004, vol. 13, no. 5, May 2004 (2004-05-01), pages 882 - 888, XP002330534, ISSN: 1055-9965 * |
KUZMIN IGOR ET AL: "Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.", CANCER RESEARCH, vol. 63, no. 8, 15 April 2003 (2003-04-15), pages 1888 - 1893, XP002330535, ISSN: 0008-5472 * |
LIN W MICHAEL ET AL: "Molecular Papanicolaou tests in the twenty-first century: Molecular analyses with fluid-based Papanicolaou technology", AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, vol. 183, no. 1, July 2000 (2000-07-01), pages 39 - 45, XP008048085, ISSN: 0002-9378 * |
NARAYAN GOPESHWAR ET AL: "Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome.", MOLECULAR CANCER [ELECTRONIC RESOURCE]., vol. 2, no. 1, 13 May 2003 (2003-05-13), pages 24.1 - 24.12, XP002330533, ISSN: 1476-4598 * |
VIRMANI A K ET AL: "Aberrant methylation during cervical carcinogenesis.", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH. MAR 2001, vol. 7, no. 3, March 2001 (2001-03-01), pages 584 - 589, XP002330531, ISSN: 1078-0432 * |
ZOU HONGZHI ET AL: "Hypermethylation of Secreted-frizzled related protein genes occurs early during neoplastic progression in Barrett's esophagus.", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING, vol. 44, July 2003 (2003-07-01), & 94TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH; WASHINGTON, DC, USA; JULY 11-14, 2003, pages 1357 - 1358, XP001206624, ISSN: 0197-016X * |
Also Published As
Publication number | Publication date |
---|---|
EP1685260A2 (en) | 2006-08-02 |
WO2005049861A2 (en) | 2005-06-02 |
JP2007531512A (en) | 2007-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006020579A3 (en) | Method for rapid identification of microorganisms | |
HK1118337A1 (en) | Methods for altering one or more parameters of a measurement system | |
WO2008039996A3 (en) | Multi-detector gas identification system | |
WO2006023769A3 (en) | Determining data quality and/or segmental aneusomy using a computer system | |
WO2006108674A3 (en) | Elite event a2704-12 and methods and kits for identifying such event in biological samples | |
WO2008084409A3 (en) | Means for identifying a strain isolated from a clinical sample at the species and/or subspecies level | |
TW200643175A (en) | Markers for prenatal diagnosis and monitoring | |
WO2005076887A3 (en) | Methods and systems for sampling, screening, and diagnosis | |
WO2004051218A8 (en) | Multiplex amplification of polynucleotides | |
WO2005017646A3 (en) | System, software and methods for biomarker identification | |
WO2006069023A3 (en) | Assay method and apparatus with reduced sample matrix effects | |
EP2145180A4 (en) | Comparative sequence analysis processes and systems | |
TW200609799A (en) | Method and apparatus for detecting temporal process variation and for managing and predicting performance of automatic classifiers | |
WO2006052822A3 (en) | Methods and devices for screening cervical cancer | |
WO2004055519A3 (en) | Specific markers for pancreatic cancer | |
WO2003048300A3 (en) | Methods of identifying cellular target molecules | |
TW200609798A (en) | Method and apparatus for detecting temporal process variation and for managing and predicting performance of automatic classifiers | |
WO2010061283A3 (en) | Biomarkers for diagnosing and detecting the progression of neurodegenerative disorders, in particular of amyotrophic lateral sclerosis | |
DE602005020592D1 (en) | CPG-AMPLICON AND ARRAY PROTOCOL | |
WO2007046108A3 (en) | Methods and kits for analyzing genetic material of a fetus | |
SG127861A1 (en) | in situ biomarker identification | |
WO2007126901A3 (en) | Apparatus and method for predicting disease | |
WO2005049861A3 (en) | Method for the analysis of gynaecological cell proliferative disorders | |
WO2006110748A3 (en) | Response gene to complement 32 (rgc-32) in disease | |
WO2005118872A3 (en) | Methods and kits for diagnosing or monitoring autoimmune and chronic inflammatory diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004797788 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006538787 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004797788 Country of ref document: EP |